Found: 6
Select item for more details and to access through your institution.
Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial
- Published in:
- Hepatology Research, 2004, v. 28, n. 3, p. 125, doi. 10.1016/j.hepres.2003.11.002
- By:
- Publication type:
- Article
Pharmacoeconomic study of biologics for psoriasis treatment based on real‐world drug survival.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 5, p. 1, doi. 10.1111/dth.15375
- By:
- Publication type:
- Article
Impact of the hospital volume and setting on postoperative complications of surgery for gastroenterological cancers in a regional area of Western Japan.
- Published in:
- Surgery Today, 2023, v. 53, n. 2, p. 214, doi. 10.1007/s00595-022-02569-6
- By:
- Publication type:
- Article
Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages.
- Published in:
- PLoS ONE, 2021, v. 16, n. 4, p. 1, doi. 10.1371/journal.pone.0248748
- By:
- Publication type:
- Article
Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 8, p. 1, doi. 10.1371/journal.pone.0237316
- By:
- Publication type:
- Article
Utilization of Common Inflammatory Markers in New, Symptomatic, Primary Care Outpatients Based on Their Cost-Effectiveness.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2003, v. 41, n. 5, p. 668, doi. 10.1515/CCLM.2003.101
- By:
- Publication type:
- Article